WEEDRoundhill Cannabis ETF
Seeks capital growth.
By Roundhill Investments · Launched 2022
Annual Cost
0.41%
#2,114 of 5,573 · average
Fund Size
$9M
#4,805 of 5,573 · small
Return (1Y)Goal
+115.7%
Track Record
4 years
#2,671 of 5,573 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$21,932+119.3%
Total-return NAV, USD. Net of fund fees, before tax.
What's inside
How Beacon categorizes this fundAsset class
EquityRegion
North americaCap
Multi cap
Strategy
Active selection
Sector
Health careFocus
Biotech & Genomics
What it actually holds
By weightConcentration
Top 8 holdings = 100.0% of fundconcentrated
TREASURY BILL
52.6%
Curaleaf Holdings Inc
21.3%
N/A
10.6%
N/A
7.5%
N/A
3.9%
First American Government Obli
1.9%
N/A
1.8%
N/A
0.4%
Asset allocation
Stocks
99.8%
Cash
0.6%
By sector
Healthcare
60.0%
Consumer Defensive
17.3%
Real Estate
16.3%
Technology
6.3%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
113.3%High
Year-on-year price swings
Max drawdown
-88.1%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.36Below average
Sortino (3Y)
0.59Moderate downside risk
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks capital growth.
- Strategy
- Actively managed ETF investing primarily in equity securities and total return swaps for exposure to the cannabis and hemp ecosystem. Focuses on companies deriving significant revenue from cannabis-related activities across various sectors, including pharmaceuticals and biotechnology.
- Inception date
- April 19, 2022
- Fund family
- Roundhill Investments
Similar funds
Closest matches by profileWhat's next?
You've looked at WEED. Save it to your watchlist to weigh it against other funds, then turn your shortlist into a portfolio.
Data updated on 2026-06-20